United States Digital Pathology Market Outlook 2025–2033: AI-Driven Diagnostics and Growth Opportunities

The United States digital pathology market was valued at USD 347.48 Million in 2024 and is projected to reach USD 853.47 Million by 2033, growing at a CAGR of 9.70% during 2025–2033. According to IMARC Group, market growth is being driven by the increasing demand for accurate and efficient diagnostic solutions, rising adoption of telepathology for remote consultations, and advancements in AI-driven image analysis. Improved workflow efficiency, innovations in slide scanners, and supportive government initiatives promoting digital healthcare infrastructure are also contributing to expansion.

As pathology workflows become more data-intensive and precision-focused, digital pathology is gaining strategic importance across hospitals, reference laboratories, pharmaceutical companies, and research institutions in the United States. The market is also benefiting from the increasing prevalence of cancer and chronic diseases, which is creating stronger demand for scalable, high-accuracy diagnostic systems.

Key Market Statistics

• Base Year: 2024
• Historical Period: 2019–2024
• Forecast Period: 2025–2033
• Market Size in 2024: USD 347.48 Million
• Market Forecast in 2033: USD 853.47 Million
• Market Growth Rate (2025–2033): 9.70%

Why B2B Stakeholders Are Tracking the United States Digital Pathology Market

For pathology software providers, scanner manufacturers, healthcare IT vendors, hospitals, reference laboratories, pharmaceutical companies, biotech firms, and investors, the United States digital pathology market presents a strong opportunity tied to precision diagnostics, pathology workflow automation, telepathology adoption, and AI-enabled decision support. The report is especially relevant for decision-makers assessing demand across product categories, deployment models, applications, and end-user groups.

Key Growth Drivers Supporting Market Expansion

Rising Demand for Faster and More Accurate Diagnostics

A major factor driving the United States digital pathology market is the rising need for faster and more accurate diagnostics. IMARC notes that growing patient volumes and increasingly complex disease cases, especially cancer, are encouraging hospitals and laboratories to adopt digital pathology systems that convert traditional glass slides into high-resolution digital images for quicker review and analysis. AI-powered tools are further improving diagnostic accuracy by automating image analysis, detecting patterns, and prioritizing critical cases.

The report also highlights that in 2024, Proscia received FDA 510(k) clearance for its Concentriq AP-Dx digital pathology software, enabling primary diagnosis using whole slide images in the United States. IMARC notes this as a significant milestone for efficiency, collaboration, and diagnostic confidence in cancer care.

Expansion of Research and Drug Development Activities

The growth of research and drug development initiatives is another major market driver. IMARC states that pharmaceutical companies, biotechnology firms, and academic research institutions are increasingly using digital pathology for preclinical studies, clinical trials, and biomarker discovery. High-resolution imaging and AI-based tools are helping accelerate research timelines, improve analytical accuracy, and support remote collaboration across large pathology datasets.

IMARC also notes that in 2024, Microsoft, the University of Washington, and Providence launched Prov-GigaPath, an AI model trained on 1.3 billion pathology images from 171,000 slides, aimed at improving cancer diagnostics by analyzing entire slides to predict gene mutations, tumor subtypes, and therapy responses.

Increasing Prevalence of Cancer and Chronic Diseases

The rising prevalence of cancer and other chronic diseases is also supporting market growth. IMARC explains that pathology remains essential in diagnosing, monitoring, and managing these conditions, creating stronger demand for advanced tools that improve both efficiency and precision. Digital pathology allows pathologists to analyze intricate tissue samples more efficiently, helping reduce diagnostic delays and support better patient outcomes.

The report further states that in 2024, Alverno Laboratories partnered with Ibex Medical Analytics to integrate AI-based pathology solutions across its Midwest network. According to IMARC, this system enhances cancer diagnosis for prostate, breast, and stomach biopsies, improving accuracy and shortening turnaround times.

United States Digital Pathology Market Segmentation Insights

IMARC Group categorizes the United States digital pathology market based on product, type, delivery model, application, end user, and region, helping stakeholders identify high-potential demand pockets across the pathology technology ecosystem.

By Product

• Scanners
• Software
• Storage Systems
• Communication Systems

By Type

• Human Pathology
• Veterinary Pathology

By Delivery Model

• On-premises
• Hosted

By Application

• Training and Education
• Consulting Services
• Intraoperative Consultation
• Routine Diagnostic Consultation Services
• Others

Routine diagnostic consultation services represent the largest application area. IMARC attributes this to digital pathology’s ability to improve efficiency and accuracy in everyday diagnostics, reduce turnaround times, and support abnormality detection through AI-based systems.

By End User

• Pharmaceutical and Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic and Research Institutes

Regional Insights

The report provides a comprehensive regional analysis of the United States digital pathology market, covering:

• Northeast
• Midwest
• South
• West

This regional structure is useful for businesses planning distributor expansion, hospital network partnerships, reference lab targeting, or region-specific commercialization strategies across the United States. That business implication is an inference based on the report’s segmentation and regional coverage.

Competitive Landscape

IMARC describes the competitive environment as one shaped by increasing investment in advanced scanners, AI-powered software, secure storage systems, and communication platforms that support telepathology and collaborative diagnostics. The report also indicates that digital pathology vendors are differentiating through workflow integration, image analysis capabilities, and support for high-volume pathology operations.

Strategic Value for Decision-Makers

The United States digital pathology market is increasingly relevant for stakeholders focused on precision diagnostics, pathology digitization, AI-assisted clinical decision-making, and research productivity. Companies that align with remote pathology workflows, scalable image storage, AI-enhanced diagnostics, and enterprise pathology integration may be better positioned to capture long-term market opportunities. This is an inference based on IMARC’s stated market drivers, product segmentation, and trend discussion.

Report Coverage

According to IMARC, the report covers historical trends, market outlook, industry catalysts and challenges, and segment-wise historical and future assessment across product, type, delivery model, application, end user, and region.

Key Benefits for Stakeholders

IMARC states that the study offers a comprehensive quantitative analysis of market segments, historical and current market trends, forecasts from 2019 to 2033, and updated information on market drivers and opportunities in the United States digital pathology market. It is designed to help stakeholders evaluate workflow modernization, technology adoption, and future growth potential across pathology-related healthcare settings.

Questions Decision-Makers Are Asking

• What is the current size of the United States digital pathology market?

The United States digital pathology market reached USD 347.48 Million in 2024.

• What is the forecast for the United States digital pathology market by 2033?

IMARC projects the market to reach USD 853.47 Million by 2033.

• What is the expected CAGR during 2025–2033?

The market is forecast to grow at a 9.70% CAGR during 2025–2033.

• What are the main factors driving market growth?

Key drivers include increasing demand for accurate and efficient diagnostic solutions, rising telepathology adoption, advancements in AI-driven image analysis, improved workflow efficiency, innovations in slide scanners, and supportive digital healthcare initiatives.

• Which product segments are covered in the report?

The report covers scanners, software, storage systems, and communication systems.

• Which type segments are analyzed?

IMARC analyzes human pathology and veterinary pathology.

• Which delivery models are included?

The market is segmented into on-premises and hosted models.

• Which application segment leads the market?

Routine diagnostic consultation services hold the largest share of the market.

• Which end-user groups are covered?

The report covers pharmaceutical and biotechnology companies, hospitals and reference laboratories, and academic and research institutes.

• Which regions are covered in the United States?

The study covers the Northeast, Midwest, South, and West.

Buy Report for Deeper Market Intelligence

The full IMARC report is designed for stakeholders seeking actionable intelligence on pathology workflow digitization, AI-enabled diagnostics, deployment trends, application demand, and end-user opportunities in the United States digital pathology market. It can support product strategy, commercial planning, healthcare partnership development, and long-term investment decisions.

Author IMARC Group

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,
Email: [email protected],
United States: +1-201971-6302